Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Artrya collaborates with healthcare facilities that treat chest pain patients to introduce innovative cardiovascular care models powered by artificial intelligence. This approach seamlessly incorporates high-prognostic plaque characteristics into the assessment of coronary artery disease. It enables swift evaluations of chest pain patients in both emergency and primary care environments. Our vision is a society free from the burden of heart attacks. Leveraging AI-generated insights from coronary computed tomography angiography (CCTA), we can rapidly and accurately classify chest pain patients based on the type and quantity of arterial plaque identified. This allows for quick identification of individuals with little to no coronary artery disease, ensuring that no underlying plaque issues could lead to significant cardiac events in the future. By recognizing early indicators of potential heart attacks, we can effectively confirm at-risk patients with acute or unusual chest pain who may require additional investigation and treatment. Ultimately, this advancement aims to enhance patient outcomes and foster a healthier community.
Description
Riverain Technologies has developed ClearRead Xray, a suite of five applications that have received FDA clearance, aimed at improving the speed and precision of interpreting chest X-rays within healthcare settings, all without the need for extra equipment, procedures, or exposure to radiation. This innovative platform utilizes specialized suppression technology to create a clear view of the chest, which significantly aids in the swift and precise identification of cardiothoracic conditions. Among its standout features are the generation of bone-suppressed images that enhance visualization, the ability to spot potential lung cancer nodules, a decrease in the time required to read portable X-rays, automatic comparisons with previous examinations to emphasize changes, and compatibility across various imaging devices and protocols throughout the enterprise. Additionally, the ClearRead Xray Bone Suppress feature notably enhances soft tissue visibility by minimizing the presence of bone structures in digital images, thereby assisting radiologists in uncovering nodules that may have previously gone unnoticed. This comprehensive approach not only boosts diagnostic capabilities but also streamlines workflow in busy medical environments.
API Access
Has API
No
API Access
Has API
No
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
No
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
Yes
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
Yes
Live Rep (24/7)
Yes
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
Yes
Vendor Details
Company Name
Artrya
Country
Australia
Website
www.artrya.com
Vendor Details
Company Name
Riverain Technologies
Founded
2004
Country
United States
Website
www.riveraintech.com/clearread-ai-solutions/clearread-xray/
Product Features
Product Features
Medical Imaging
Automated Routing
No
Comparison View
No
Compliance Management
No
Data Import / Export
No
Diagnostic Reporting
No
Image Analytics
No
Treatment Planning
No
Workflow Management
No
Radiology
Audit Trail
No
Billing & Invoicing
No
Claims Management
No
EDI
No
EMR HL7 Bridge
No
Image Fusion
No
PACS Integration
No
Patient Scheduling
No
Scanning Input
No
Teleradiology
No
Wait List Management
No